Patrick J. Haley - 03 Mar 2025 Form 4 Insider Report for EXELIXIS, INC. (EXEL)

Signature
/s/ Nina Ayer, Attorney in Fact
Issuer symbol
EXEL
Transactions as of
03 Mar 2025
Transactions value $
-$388,000
Form type
4
Filing time
05 Mar 2025, 20:47:52
Previous filing
28 Feb 2025
Next filing
31 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EXEL Common Stock Sale -$388K -10K -2.85% $38.80 341K 03 Mar 2025 Direct F1, F2
holding EXEL Common Stock 23.5K 03 Mar 2025 By spouse
holding EXEL Common Stock 10.6K 03 Mar 2025 By 401(k) F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2024.
F2 Includes 282,985 shares of Exelixis, Inc. common stock ("Common Stock") that will be issued to the Reporting Person upon vesting of restricted stock units.
F3 Represents shares of Common Stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of March 3, 2025.